Table 2.

Consumption of antibiotics demonstrating anti-pseudomonas aeruginosa activity.

Category	Consumption	Pre-AST	Post-AST	U-Value	p-Value
Carbapenem	DOT	9.2 (4.2–16.1)	7.1 (2.7–15.0)	270.0	0.015 *
	AUD	8.4 (2.7–15.1)	6.6 (2.2–15.2)	281.0	0.023 *
Tazobactam/piperacillin	DOT	44.5 (4.6–73.8)	47.4 (14.6–145.0)	509.0	0.245
	AUD	37.7 (3.7–75.6)	40.8 (10.6–127.1)	480.0	0.469
Fourth-generation cephalosporins	DOT	95.2 (40.8–139.3)	67.1 (0.0–151.2)	271.0	0.015 *
	AUD	79.3 (37.6–121.8)	27.7 (0.0–102.0)	65.0	<0.001 *
Third-generation cephalosporins	DOT	15.7 (0.0–67.8)	56.5 (0.0–155.8)	716.0	<0.001 *
	AUD	10.0 (0.0–48.6)	39.2 (0.0–94.2)	715.0	<0.001 *

Median (interquartile range). Abbreviations are as follows: AST, antimicrobial stewardship team. * p < 0.05.